Microsoft's dominant position across enterprise software, cloud (Azure), and AI tools creates an unbreakable moat and pricing power. Azure accelerating to 40% growth with strong balance sheet supports sustained upside as mega caps rotate higher.
Microsoft is a long-term compounder that will obviously outperform in retrospect. The author believes it's a high-conviction bet worth committing significant capital to.
Author bought MSFT near $400 support after a multi-week decline, executing quick scalping trades on intraday moves. Noted the stock's strong $20-point pop despite broader market weakness and European tech skepticism, suggesting underlying strength at current levels.
Bill Ackman's Pershing Square has taken a stake in Microsoft citing compelling valuation, implying the stock is undervalued and positioned for upside from a major activist investor.
MSFT has begun to inverse QQQ, suggesting a divergence that signals weakness. The author sold their calls based on this technical warning sign.
Author is funneling big pharma internship paychecks into Microsoft (referred to colloquially as 'macrohard'). The post suggests a bullish conviction strong enough to commit earned income to the position.
Author is making a 230K CAD bet on MSFT, treating a speculative position as a long-term investment after having previously played earnings unsuccessfully.
Author is going all-in on MSFT before earnings, betting on upside to reach $500 by end of year. Self-aware skepticism about the bet's viability suggests thin conviction but directional bullish exposure.
End of results.